Delivery Order SPE2DB22D1202-SPE2DB25FURL1

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,978.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,770,551 units of Methylphenidate ER (CD) 20mg Capsules, a medication used to treat ADHD. The contract has a firm fixed price and a completion date of December 18, 2024. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,105.18 firm fixed-price delivery order is for the supply of 10 mg capsules of the medication Methylphenidate LA, a branded generic drug used to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $6,192.97, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of methylphenidate hydrochloride tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD) and other conditions. The contract is a delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract...
The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567012933 - Methylphenidate LA 10 mg capsules in 100-count packages. The contract has a ceiling value of $1,972.30 and a performance period through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at...
This federal contract award, valued at $1,409.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of 54 mg Methylphenidate Extended Release, a medication used to treat ADHD. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.22 firm-fixed-price delivery order is for the supply of 4,566,504,596 tablets of 27mg extended-release methylphenidate, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,767,044 units of Methylphenidate ER 27 mg tablets, a prescription medication used to treat ADHD. The total ceiling value of the contract is $1,010.73, and it is a firm fixed price delivery order contract type. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.06 firm fixed-price delivery order is for the supply of 100 tablets of 54 mg Methylphenidate ER, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $3,563.22, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of Methylphenidate LA 10 mg capsules in 100-count bottles. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and runs through December 2025. This IDC serves as the primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,221.92, is for the delivery of 4,564,275,363 units of Methylphenidate LA 30mg in 100-count bottles. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FURL1
    Delivery Order

This federal contract award, valued at $1,358.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,136,732 units of Methylphenidate LA 10 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD).

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:05 AM